Goa Carbons Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:35 am

Competitors of Goa Carbons Ltd

All Competitor Stocks of Goa Carbons Ltd

Quarterly Result

Last Updated: August 20, 2025, 10:20 am

Below is a detailed analysis of the quarterly data for Goa Carbons Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 199.25 Cr.. The value appears strong and on an upward trend. It has increased from 132.19 Cr. (Mar 2025) to 199.25 Cr., marking an increase of 67.06 Cr..
• For Expenses, as of Jun 2025, the value is 207.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 136.97 Cr. (Mar 2025) to 207.04 Cr., marking an increase of 70.07 Cr..
• For Operating Profit, as of Jun 2025, the value is -7.79 Cr.. The value appears to be declining and may need further review. It has decreased from -4.78 Cr. (Mar 2025) to -7.79 Cr., marking a decrease of 3.01 Cr..
• For OPM %, as of Jun 2025, the value is -3.91%. The value appears to be declining and may need further review. It has decreased from -3.62% (Mar 2025) to -3.91%, marking a decrease of 0.29%.
• For Other Income, as of Jun 2025, the value is 1.72 Cr.. The value appears to be declining and may need further review. It has decreased from 1.88 Cr. (Mar 2025) to 1.72 Cr., marking a decrease of 0.16 Cr..
• For Interest, as of Jun 2025, the value is 4.94 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.56 Cr. (Mar 2025) to 4.94 Cr., marking an increase of 0.38 Cr..
• For Depreciation, as of Jun 2025, the value is 0.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.73 Cr. (Mar 2025) to 0.77 Cr., marking an increase of 0.04 Cr..
• For Profit before tax, as of Jun 2025, the value is -11.78 Cr.. The value appears to be declining and may need further review. It has decreased from -8.19 Cr. (Mar 2025) to -11.78 Cr., marking a decrease of 3.59 Cr..
• For Tax %, as of Jun 2025, the value is -32.51%. The value appears to be improving (decreasing) as expected. It has decreased from -20.15% (Mar 2025) to -32.51%, marking a decrease of 12.36%.
• For Net Profit, as of Jun 2025, the value is -7.95 Cr.. The value appears to be declining and may need further review. It has decreased from -6.54 Cr. (Mar 2025) to -7.95 Cr., marking a decrease of 1.41 Cr..
• For EPS in Rs, as of Jun 2025, the value is -8.69. The value appears to be declining and may need further review. It has decreased from -7.15 (Mar 2025) to -8.69, marking a decrease of 1.54.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:19 am

Growth

Last Updated: September 5, 2025, 5:00 am

Balance Sheet

Last Updated: November 9, 2025, 2:04 pm

Below is a detailed analysis of the balance sheet data for Goa Carbons Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
• For Reserves, as of Sep 2025, the value is 179.00 Cr.. The value appears to be declining and may need further review. It has decreased from 208.00 Cr. (Mar 2025) to 179.00 Cr., marking a decrease of 29.00 Cr..
• For Borrowings, as of Sep 2025, the value is 391.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 281.00 Cr. (Mar 2025) to 391.00 Cr., marking an increase of 110.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing). It has decreased from 32.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 610.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 531.00 Cr. (Mar 2025) to 610.00 Cr., marking an increase of 79.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 1.00 Cr..
• For CWIP, as of Sep 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
• For Other Assets, as of Sep 2025, the value is 568.00 Cr.. The value appears strong and on an upward trend. It has increased from 493.00 Cr. (Mar 2025) to 568.00 Cr., marking an increase of 75.00 Cr..
• For Total Assets, as of Sep 2025, the value is 610.00 Cr.. The value appears strong and on an upward trend. It has increased from 531.00 Cr. (Mar 2025) to 610.00 Cr., marking an increase of 79.00 Cr..

However, the Borrowings (391.00 Cr.) are higher than the Reserves (179.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Goa Carbons Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 17, the value is 9.95. This value is within the healthy range. It has increased from -3.71 (Mar 16) to 9.95, marking an increase of 13.66.
• For Diluted EPS (Rs.), as of Mar 17, the value is 9.95. This value is within the healthy range. It has increased from -3.71 (Mar 16) to 9.95, marking an increase of 13.66.
• For Cash EPS (Rs.), as of Mar 17, the value is 12.02. This value is within the healthy range. It has increased from -1.67 (Mar 16) to 12.02, marking an increase of 13.69.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 87.89. It has increased from 79.74 (Mar 16) to 87.89, marking an increase of 8.15.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 87.89. It has increased from 79.74 (Mar 16) to 87.89, marking an increase of 8.15.
• For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 318.09. It has decreased from 345.34 (Mar 16) to 318.09, marking a decrease of 27.25.
• For PBDIT / Share (Rs.), as of Mar 17, the value is 26.13. This value is within the healthy range. It has increased from 13.41 (Mar 16) to 26.13, marking an increase of 12.72.
• For PBIT / Share (Rs.), as of Mar 17, the value is 24.06. This value is within the healthy range. It has increased from 11.37 (Mar 16) to 24.06, marking an increase of 12.69.
• For PBT / Share (Rs.), as of Mar 17, the value is 16.75. This value is within the healthy range. It has increased from -5.25 (Mar 16) to 16.75, marking an increase of 22.00.
• For Net Profit / Share (Rs.), as of Mar 17, the value is 9.95. This value is within the healthy range. It has increased from -3.71 (Mar 16) to 9.95, marking an increase of 13.66.
• For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 9.95. This value is within the healthy range. It has increased from -3.71 (Mar 16) to 9.95, marking an increase of 13.66.
• For PBDIT Margin (%), as of Mar 17, the value is 8.21. This value is below the healthy minimum of 10. It has increased from 3.88 (Mar 16) to 8.21, marking an increase of 4.33.
• For PBIT Margin (%), as of Mar 17, the value is 7.56. This value is below the healthy minimum of 10. It has increased from 3.29 (Mar 16) to 7.56, marking an increase of 4.27.
• For PBT Margin (%), as of Mar 17, the value is 5.26. This value is below the healthy minimum of 10. It has increased from -1.52 (Mar 16) to 5.26, marking an increase of 6.78.
• For Net Profit Margin (%), as of Mar 17, the value is 3.12. This value is below the healthy minimum of 5. It has increased from -1.07 (Mar 16) to 3.12, marking an increase of 4.19.
• For NP After MI And SOA Margin (%), as of Mar 17, the value is 3.12. This value is below the healthy minimum of 8. It has increased from -1.07 (Mar 16) to 3.12, marking an increase of 4.19.
• For Return on Networth / Equity (%), as of Mar 17, the value is 11.32. This value is below the healthy minimum of 15. It has increased from -4.64 (Mar 16) to 11.32, marking an increase of 15.96.
• For Return on Capital Employeed (%), as of Mar 17, the value is 25.83. This value is within the healthy range. It has increased from 13.92 (Mar 16) to 25.83, marking an increase of 11.91.
• For Return On Assets (%), as of Mar 17, the value is 3.44. This value is below the healthy minimum of 5. It has increased from -1.12 (Mar 16) to 3.44, marking an increase of 4.56.
• For Total Debt / Equity (X), as of Mar 17, the value is 1.97. This value exceeds the healthy maximum of 1. It has decreased from 2.81 (Mar 16) to 1.97, marking a decrease of 0.84.
• For Asset Turnover Ratio (%), as of Mar 17, the value is 1.03. It has decreased from 1.14 (Mar 16) to 1.03, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 17, the value is 1.22. This value is below the healthy minimum of 1.5. It has increased from 1.12 (Mar 16) to 1.22, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 17, the value is 0.75. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 16) to 0.75, marking an increase of 0.02.
• For Inventory Turnover Ratio (X), as of Mar 17, the value is 2.65. This value is below the healthy minimum of 4. It has decreased from 2.71 (Mar 16) to 2.65, marking a decrease of 0.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 17, the value is 15.07. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 16) to 15.07, marking an increase of 15.07.
• For Dividend Payout Ratio (CP) (%), as of Mar 17, the value is 12.48. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 16) to 12.48, marking an increase of 12.48.
• For Earning Retention Ratio (%), as of Mar 17, the value is 84.93. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 16) to 84.93, marking an increase of 84.93.
• For Cash Earning Retention Ratio (%), as of Mar 17, the value is 87.52. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 16) to 87.52, marking an increase of 87.52.
• For Interest Coverage Ratio (X), as of Mar 17, the value is 3.57. This value is within the healthy range. It has increased from 0.80 (Mar 16) to 3.57, marking an increase of 2.77.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 2.36. This value is below the healthy minimum of 3. It has increased from 0.77 (Mar 16) to 2.36, marking an increase of 1.59.
• For Enterprise Value (Cr.), as of Mar 17, the value is 164.63. It has increased from 142.04 (Mar 16) to 164.63, marking an increase of 22.59.
• For EV / Net Operating Revenue (X), as of Mar 17, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 16) to 0.56, marking an increase of 0.12.
• For EV / EBITDA (X), as of Mar 17, the value is 6.88. This value is within the healthy range. It has decreased from 11.57 (Mar 16) to 6.88, marking a decrease of 4.69.
• For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 0.36. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 16) to 0.36, marking an increase of 0.15.
• For Retention Ratios (%), as of Mar 17, the value is 84.92. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 16) to 84.92, marking an increase of 84.92.
• For Price / BV (X), as of Mar 17, the value is 1.33. This value is within the healthy range. It has increased from 0.93 (Mar 16) to 1.33, marking an increase of 0.40.
• For Price / Net Operating Revenue (X), as of Mar 17, the value is 0.36. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 16) to 0.36, marking an increase of 0.15.
• For EarningsYield, as of Mar 17, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 16) to 0.08, marking an increase of 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness